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418A The Journal of Thoracic an4 The birth of the elephant trunk technique(continued on page 20A
d Cardiovascular Surgery c January 2013Hans G. Borst, MDCardiothoracic Surgical
Education and Training
(EDU)
45 Teaching behaviors in the cardiac surgery simulation environment
James I. Fann, MD, Maura E. Sullivan, PhD, Kelley M. Skeff, MD, PhD, Georgette A. Stratos, PhD,
Jennifer D. Walker, MD, Eugene A. Grossi, MD, Edward D. Verrier, MD, George L. Hicks, Jr, MD,
and Richard H. Feins, MD, Stanford and Los Angeles, Calif; Boston, Mass; New York and
Rochester, NY; Seattle, Wash; and Chapel Hill, NCAt Boot Camp, we used a framework to assess teaching behaviors in skills training of 24
cardiothoracic surgery residents by 20 faculty. Simulation is perceived by residents to be associated
with positive teaching behaviors. Faculty self-ratings suggest that their performance can be
improved. The simulation setting may provide greater opportunity for positive teaching behaviors
compared with the clinical environment.54 Assessment of a mitral valve replacement skills trainer: A simplified, low-cost
approach
David G. Greenhouse, MD, Eugene A. Grossi, MD, Sophia Dellis, BA, Joy Park, BS,
David W. Yaffee, MD, Abe DeAnda, Jr, MD, Aubrey C. Galloway, MD, and Leora B. Balsam, MD,
New York, NYSimulated mitral valve replacement may aid in assessing technical skills required for surgical
proficiency. We designed a low-cost, portable skills trainer and demonstrated that performance of
simulatedmitral valve replacement varied by level of training. This training station may be useful in
a surgical skills curriculum for competency evaluation.General Thoracic
Surgery (GTS)
60 Pulmonary resections performed at hospitals with thoracic surgery residency
programs have superior outcomes
Castigliano M. Bhamidipati, DO, PhD, MSc, George J. Stukenborg, PhD, Gorav Ailawadi, MD,
Christine L. Lau, MD, Benjamin D. Kozower, MD, MPH, and David R. Jones, MD, Charlottesville,
VaPulmonary resections are performed at teaching and nonteaching hospitals. Results comparing
outcomes among various hospital subtypes suggest that hospitals with thoracic surgery residencies
are independently associated with lowering morbidity and mortality. Thus, hospitals with thoracic
surgery residency teaching programs should become an independent prognostic indicator of
outcomes after pulmonary resections.68 A comparison of quality and cost indicators by surgical specialty for lobectomy
of the lung
Richard K. Freeman, MD, MBA, J. Russell Dilts, MS, Anthony J. Ascioti, MD,
Theresa Giannini, ARNP, and Raja J. Mahidhara, MD, Indianapolis, Ind, and St Louis, MoThis review found that currently measurable indicators for quality of care were significantly
superior and overall charges were significantly reduced when lobectomy for non–small cell lung
cancer was performed by a cardiothoracic surgeon rather than a general surgeon. These finding may
have implications for facility and payer physician credentialing.)
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PM720A The Journal of Thoracic an5 Patterns of recurrence and second primary lung cancer in early-stage
lung cancer survivors followed with routine computed tomography
surveillance(continued on page 23A
d Cardiovascular Surgery c January 2013Feiran Lou, MD, MS, James Huang, MD, MS, Camelia S. Sima, MD, MS, Joseph Dycoco, BA,
Valerie Rusch, MD, and Peter B. Bach, MD, MAPP, New York, NYRoutine surveillance CT scan detected the majority of second primary lung cancers and
recurrences, but it may be more sensitive for second primary cancers. The risk of recurrence after
curative resection for early-stage NSCLC persisted during the first 4 years after resection.83 Resection and heated pleural chemoperfusion in patients with thymic
epithelial malignant disease and pleural spread: A single-institution
experience
Alon Yellin, MD, David A. Simansky, MD, Ronny Ben-Avi, MD, Marina Perelman, MD,
Nona Zeitlin, MD, Yael Refaely, MD, and Alon Ben-Nun, MD, Tel Hashomer, IsraelResection and heated pleural chemoperfusion with cisplatinum and doxorubicin (adriamycin) using
a roller pump and heat exchanger is a simple and safe method for treating thymic epithelial tumors
with pleural spread. It provides excellent long-term survival andmoderate progression-free survival
for thymoma. Results with thymic carcinoma are disappointing.90 Technical aspects and early results of robotic esophagectomy with chest
anastomosis
Robert James Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD, and
Mary T. Hawn, MD, MPH, FACS, Birmingham, AlaA completely portal robotic esophagectomy is safe, affords a thorough thoracic lymphadenectomy,
R0 resection and minimal blood loss, and the ability to perform a 2-layered hand-sewn chest
anastomosis with good early results. Technical details and lessons learned are presented.97 The role of hepatic metastases and pulmonary tumor burden in predicting
survival after complete pulmonary resection for colorectal cancer
Francesco Sclafani, MD, Matteo Incarbone, MD, Lorenza Rimassa, MD, Nicola Personeni, MD,
Laura Giordano, Marco Alloisio, MD, and Armando Santoro, MD, Rozzano, ItalyIn past decades, the number of patients with colorectal cancer deemed eligible for curative resection
of metastases has significantly increased. However, prognostic factors predicting survival after
complete pulmonary resection are still debated. This study indicates the presence of a single
pulmonary metastasis as the only favorable predictor of survival.Acquired Cardiovascular
Disease (ACD)
104 Early outcome of folding mitral valve repair technique without resection for
mitral valve prolapse in 60 patients
Hiroyuki Tsukui, MD, PhD, Nobuhiro Umehara, MD, Hiroyuki Saito, MD, PhD,
Satoshi Saito, MD, PhD, and Kenji Yamazaki, MD, PhD, Tokyo, JapanFMVR is a nonresectional technique with inversion of the prolapsed segment into the left ventricle.
FMVR is an easily fine-tuned technique with a pilot suture, which can be easily removed and
repositioned, if unsatisfactory. This reversibility is a significant advantage of this technique.)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 145, Number 1 23AEDAlfred A. Kocher, MD, PhD, G€unther Laufer, MD, PhD, Axel Haverich, MD, PhD,
Malakh Shrestha, MD, PhD, MBBS, Thomas Walther, MD, PhD, Martin Misfeld, MD, PhD,
Joerg Kempfert, MD, Linda Gillam, MD, MPH, Christoph Schmitz, MD,
Thorsten C. Wahlers, MD, PhD, Jens Wippermann, MD, Friedrich W. Mohr, MD, PhD,
Matthias Roth, MD, Adalbert Skwara, MD, Parwis Rahmanian, MD, Dominik Wiedemann, MD,
and Michael A. Borger, MD, PhD, Vienna, Austria; Hannover, Bad Nauheim, Leipzig, Munich, and
Cologne, Germany; and New York, NYG
TSA rapid-deployment valve system may facilitate less-invasive surgical approaches and reduce
crossclamp and bypass times in aortic valve replacement. One-year outcomes of the multicenter
TRITON trial with the EDWARDS INTUITY Valve System support the safety, feasibility, and
efficacy of this rapid-deployment valve system for aortic valve replacement.1D17 David valve-sparing aortic root replacement: Equivalent mid-term outcome for
different valve types with or without connective tissue disorderC
AJohn-Peder Escobar Kvitting, MD, PhD, Fabian A. Kari, MD, Michael P. Fischbein, MD, PhD,
David H. Liang, MD, PhD, Anne-Sophie Beraud, MD, Elizabeth H. Stephens, MD, PhD,
R. Scott Mitchell, MD, and D. Craig Miller, MD, Stanford, CalifThe results of Tirone David V-SARR in patients with and without CTDs or BAV disease were
analyzed in 233 patients. V-SARR was associated with excellent clinical and echocardiographic
outcome, irrespective of whether BAVor CTD was present.128 Mitral valve repair or replacement for ischemic mitral regurgitation?
The Italian Study on the Treatment of Ischemic Mitral Regurgitation
(ISTIMIR)CH
DTXRoberto Lorusso, MD, PhD, Sandro Gelsomino, MD, PhD, Enrico Vizzardi, MD,
Antonio D’Aloia, MD, Giuseppe De Cicco, MD, Fabiana Luca, MD, Orlando Parise, MSc,
Gian Franco Gensini, MD, Pierluigi Stefano, MD, Ugolino Livi, MD, Igor Vendramin, MD,
Davide Pacini, MD, Roberto Di Bartolomeo, MD, Antonio Miceli, MD, PhD, Egidio Varone, MD,
Mattia Glauber, MD, Alessandro Parolari, MD, Francesco Giuseppe Arlati, MD,
Francesco Alamanni, MD, Filiberto Serraino, MD, Attilio Renzulli, MD, Antonio Messina, MD,
PhD, Giovanni Troise, MD, Giovanni Mariscalco, MD, PhD, Marzia Cottini, MD,
Cesare Beghi, MD, Francesco Nicolini, MD, PhD, Tiziano Gherli, MD, Valentino Borghetti, MD,
Alessandro Pardini, MD, Philippe-Primo Caimmi, MD, Ezio Micalizzi, MD, Carlo Fino, MD,
Paolo Ferrazzi, MD, Michele Di Mauro, MD, and Antonio Maria Calafiore, MD, the ISTIMIR
Investigators, Brescia, Florence, Udine, Bologna, Massa, Milan, Catanzaro, Varese, Parma, Terni,
Novara, Bergamo, and Catania, Italy
PMThe impact of mitral valve repair and replacement was assessed with a multicenter, retrospective,
propensity score study in 448 matched patients affected by chronic ischemic mitral regurgitation
and left ventricular dysfunction. No significant difference was found between groups in terms of
postoperative survival and left ventricular function change. Patients who underwent mitral repair
showed a higher reoperation rate for recurrence of mitral regurgitation.) ET
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PM124A The Journal of Thoracic an40 Should all moderate coronary lesions be grafted during primary coronary
bypass surgery? An analysis of progression of native vessel disease during
a randomized trial of conduits(continued on page 26A
d Cardiovascular Surgery c January 2013Philip A. Hayward, FRCS, Ying Yan Zhu, BMedSci, Trong T. Nguyen, BMedSci,
David L. Hare, FRACP, and Brian F. Buxton, FRCS, Melbourne, AustraliaThe decision to graft a moderately stenosed coronary lesion depends on a number of factors,
including progression of native vessel disease and graft patency. Data from pre- and
postoperative angiography of a cohort of predominately asymptomatic patients suggests that
left-sided moderate lesions are best treated by bypass grafting whereas right-sided lesions may be
reasonably left alone.150 Contemporary patterns of surgery and outcomes for aortic coarctation: An
analysis of the Society of Thoracic Surgeons Congenital Heart Surgery
Database
Ross M. Ungerleider, MD, MBA, Sara K. Pasquali, MD, Karl F. Welke, MD, Amelia S. Wallace, BS,
Yoshio Ootaki, MD, PhD, Michael D. Quartermain, MD, Derek A. Williams, DO, and
Jeffrey P. Jacobs, MD, Winston Salem and Durham, NC; Seattle, Wash; and Saint Petersburg and
Tampa, FlaThis study reviews 5025 patients with aortic coarctaion or hypoplastic aortic arch repair in the STS
Congenital Heart Surgery Database between 2006 and 2010. Operative/hospital mortality ranges
from 1% (isolated coarctaion) to 2.5% (coarctaion 1 VSD) to 4.8% (coarctaion 1 other complex
heart defect). Complications are common (36% overall) but the incidence of paraplegia in this
series is 0%.159 Midterm results after endovascular treatment of acute, complicated type B
aortic dissection: The Talent Thoracic Registry
Marek P. Ehrlich, MD, Herve Rousseau, MD, Robin Heijmen, MD, Philippe Piquet, MD,
Jean-Paul Beregi, MD, Christoph A. Nienaber, MD, Gottfried Sodeck, MD, and
Rossella Fattori, MD, Vienna, Austria; Toulouse, Marseille, and Lille, France; Nieuwegein,
The Netherlands; Rostock, Germany; and Bologna, ItalyDuring the past decade, endovascular techniques have revolutionized the treatment of
descending thoracic aortic disease. The present study was undertaken to analyze midterm outcome
on patients who underwent endovascular stent graft placement for acute complicated type B aortic
dissections.166 Effects of institutional volumes on operative outcomes for aortic root
replacement in North America
G. Chad Hughes, MD, Yue Zhao, PhD, J. Scott Rankin, MD, John E. Scarborough, MD,
Sean O’Brien, PhD, Joseph E. Bavaria, MD, Walter G. Wolfe, MD, Jeffrey G. Gaca, MD,
James S. Gammie, MD, David M. Shahian, MD, and Peter K. Smith, MD, Durham, NCThe present study sought to evaluate the relationship between the volume of aortic root replacement
procedures and the operative results in North America. Patients undergoing elective aortic root or
combined aortic valve-ascending aortic surgery at hospitals that performed fewer than 30 to 40 such
procedures annually had significantly greater risk-adjusted mortality than those undergoing surgery
in higher volume hospitals.)
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PM126A The Journal of Thoracic an71 Asymmetric septal hypertrophy in patients with severe aortic stenosis: The
usefulness of associated septal myectomy(continued on page 28A
d Cardiovascular Surgery c January 2013Luigi Di Tommaso, MD, Paolo Stassano, MD, Vito Mannacio, MD, Veronica Russolillo, MD,
Mario Monaco, MD, Giovanni Pinna, MD, and Carlo Vosa, MD, Naples, ItalyAsymmetric septal hypertrophy frequently coexists with severe AS. In 86 patients who underwent
AVR, with or without concomitant myectomy, we investigated the effectiveness of myectomy on
LV mass regression and diastolic function. The LV mass index regressed more in patients with
concomitant myectomy with consequent improvement in diastolic function.Congenital Heart
Disease (CHD)
176 Outcomes of interrupted aortic arch repair using the carotid artery turndown
procedure
Steven H. Todman, MD, Osama Eltayeb, MD, Mark Ruzmetov, MD, PhD, Mark D. Rodefeld, MD,
Mark W. Turrentine, MD, John W. Brown, MD, and John P. Breinholt, MD, Indianapolis, IndThe left carotid artery turndown technique for repair of interrupted aortic arch represents a surgical
modality that requires a 2-stage surgical repair and can be performed with results comparable to
those for other modalities without neonatal exposure to circulatory arrest and cardiopulmonary
bypass.183 Fontan fenestration closure and event-free survival
Bartlomiej R. Imielski, BS, Ronald K. Woods, MD, PhD, Kathleen A. Mussatto, PhD, RN,
Yumei Cao, PhD, Pippa M. Simpson, PhD, and James S. Tweddell, MD, Milwaukee, WisIn the present cohort of 212 fenestrated Fontan patients, fenestration closure was associated with
greater arterial oxygen saturation but not with greater event-free survival. The interval to an event
was shorter than the interval to closure.188 The impact of temperature and pump flow rate during selective cerebral
perfusion on regional blood flow in piglets
Jian Wang, MD, PhD, Richard M. Ginther, CCP, Matthew Riegel, DVM, Rong Huang, MS,
Mahesh S. Sharma, MD, Kristine J. Guleserian, MD, and Joseph M. Forbess, MD, Dallas, TexSelective cerebral perfusion at 32C provides higher blood flow in all investigated regions of the
brain after cardiopulmonary bypass. This suggests that mild hypothermia might allow for better
brain perfusion during selective cerebral perfusion.196 Early postoperative changes in cerebral oxygen metabolism following neonatal
cardiac surgery: Effects of surgical duration
Erin M. Buckley, PhD, Jennifer M. Lynch, MS, Donna A. Goff, MD, Peter J. Schwab, BA,
Wesley B. Baker, MS, Turgut Durduran, PhD, David R. Busch, PhD, Susan C. Nicolson, MD,
Lisa M. Montenegro, MD, Maryam Y. Naim, MD, Rui Xiao, PhD, Thomas L. Spray, MD,
A. G. Yodh, PhD, J. William Gaynor, MD, and Daniel J. Licht, MD, Philadelphia, Pa, Loma Linda,
Calif, and Barcelona, SpainDiffuse optical spectroscopies were used to quantify changes in cerebral metabolic rate of oxygen
during the early postoperative period relative to preoperative levels in neonates with congenital
heart defects. After dichotomizing by cardiac physiology, total support time and deep hypothermic
circulatory arrest duration were not significant predictors of a relative change in cerebral metabolic
rate of oxygen.)
Table of Contents (continued)
ED
ITO
RIA
L
TX
ED
U
G
TS
A
CD
CH
D
ET/B
S
PM228A The Journal of Thoracic an06 Bilateral pulmonary artery banding for resuscitation in high-risk,
single-ventricle neonates and infants: A single-center experience(continued on page 30A
d Cardiovascular Surgery c January 2013Kristine J. Guleserian, MD, Gregory M. Barker, MD, Mahesh S. Sharma, MD, Joy Macaluso, RN,
Rong Huang, PhD, Alan W. Nugent, MBBS, and Joseph M. Forbess, MD, Dallas, TexbPAB, with either ductal stenting or maintenance of PGE1 infusion, is an effective method of
resuscitation for high-risk neonates and infants with a SV and allows for reasonable survival to
either conventional first-stage palliation or transplantation, when appropriate.Cardiothoracic
Transplantation (TX)
215 Effect of cytokine hemoadsorption on brain death–induced ventricular
dysfunction in a porcine model
Krasimira M. Mikhova, BSE, Creighton W. Don, MD, PhD, Michael Laflamme, MD, PhD,
John A. Kellum, MD, Michael S. Mulligan, MD, Edward D. Verrier, MD, and David G. Rabkin, MD,
Seattle, Wash, and Pittsburgh, PaCytokine hemoadsorption, beginning 3 hours after the induction of brain death, attenuated both
systolic and diastolic indices of left ventricular dysfunction, improved cardiac output and mean
arterial pressure, and prevented the development of myocardial edema in an open-chest porcine
model. Further investigation of the mechanism of this effect is warranted.Perioperative
Management (PM)
225 Physician assistant home visit program to reduce hospital readmissions
John P. Nabagiez, MD,Masood A. Shariff, MD,Muhammad A. Khan, MD,William J. Molloy, PA-C,
and Joseph T. McGinn, Jr, MD, Staten Island, NYPhysician assistants made postoperative house calls to patients who had undergone cardiac surgery.
The 30-day readmission rate decreased by 25%. The rate of readmission for infectious diagnoses
decreased by 54%. The most common intervention during house calls was medication adjustment,
most commonly diuretics, hypoglycemics, and antibiotics.234 Putting the record straight on aprotinin as safe and effective: Results from
a mixed treatment meta-analysis of trials of aprotinin
Neil Howell, PhD, FRCS(C-Th), Eshan Senanayake, MRCS, Nick Freemantle, PhD, and
Domenico Pagano, MD, FRCS(C-Th), Birmingham and London, UKThis new mixed treatment comparisons network meta-analysis including BART shows no
difference in mortality between placebo and antifibrinolytic agents. Analysis of aprotinin versus
tranexamic acid and e-aminocaproic acid shows no difference in mortality, and there is no increased
risk of mortality with aprotinin relative to other agents.Commentary 240 Facts, opinions, and conclusions: Aprotinin brings out all of these
Victor A. Ferraris, MD, PhD, Lexington, Ky243 Coronary artery bypass grafting after aprotinin: Are we doing better?
Ziv Beckerman, MD, Yoni Shopen, MD, Hagar Alon, MD, Oved Cohen, MD,
Rony-Reuven Nir, PhD, Zvi Adler, MD, and Gil Bolotin, MD, PhD, Haifa, IsraelThe efficacy and safety of aprotinin versus tranexamic acid in elective coronary artery bypass
surgery patients was reevaluated. Among low-risk patients, aprotinin was more effective in terms of
bleeding and infusion of blood products, with no evidence of associated augmented rates of
postoperative complications. Aprotinin should be reconsidered for treatment of low-risk patients.)
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230A The Journal of Thoracic an49 Performance evaluation of a pediatric viscous impeller pump for Fontan
cavopulmonary assist(continued on page 31A
d Cardiovascular Surgery c January 2013Guruprasad A. Giridharan, PhD, Steven C. Koenig, PhD, Jeffrey Kennington, BS,
Michael A. Sobieski, RN, CCP, Jun Chen, PhD, Steven H. Frankel, PhD, and
Mark D. Rodefeld, MD, Louisville, Ky; and Lafayette and Indianapolis, IndThe performance of a catheter-based, expandable, viscous impeller pump (VIP) to provide
cavopulmonary support in pediatric Fontan patients was evaluated. The VIP augmented total
cavopulmonary flow at pediatric scales and normalized systemic pressures and flows to
biventricular values, without causing flow obstruction or suction and has low hemolysis risk.258 Metformin alters the insulin signaling pathway in ischemic cardiac tissue in
a swine model of metabolic syndrome
Nassrene Y. Elmadhun, MD, Antonio D. Lassaletta, MD, Louis M. Chu, MD, and
Frank W. Sellke, MD, Providence, RIMetformin treatment in the context of metabolic syndrome and myocardial ischemia dramatically
upregulates the insulin signaling pathway in chronically ischemic myocardium, which is at the
crossroads of known metabolic and survival benefits of metformin.267 Differential membrane type 1 matrix metalloproteinase substrate processing
with ischemia–reperfusion: Relationship to interstitial microRNA dynamics
and myocardial function
Shaina R. Eckhouse, MD, Adam W. Akerman, MS, Christina B. Logdon, MVT,
J. Marshall Oelsen, BS, Elizabeth C. O’Quinn, BS, Elizabeth K. Nadeau, BS,
Robert E. Stroud, MS, Rupak Mukherjee, PhD, Jeffrey A. Jones, PhD, and
Francis G. Spinale, MD, PhD, Charleston and Columbia, SCIn a porcine model of myocardial ischemia–reperfusion, there was early induction of proteolytic as
well as profibrotic pathways and coincided with dynamic changes in interstitial microRNA-133a.
These unique findings suggest that microRNA-133a modulation represents a novel mechanism for
regulating myocardial remodeling events after ischemia–reperfusion.278 Mathematically engineered stromal cell–derived factor-1a stem cell cytokine
analog enhances mechanical properties of infarcted myocardium
John W. MacArthur, Jr, MD, Alen Trubelja, BS, Yasuhiro Shudo, MD, Philip Hsiao, BA,
Alexander S. Fairman, BA, Elaine Yang, MS, William Hiesinger, MD, Joseph J. Sarver, PhD,
Pavan Atluri, MD, and Y. Joseph Woo, MD, Philadelphia, PaDirect injection of an engineered stromal cell-derived factor-1a analog around the border zone of
an infarct reduces ventricular remodeling and improves the biomechanical properties of the
myocardial tissue.285 Using contracting band to improve right ventricle ejection fraction for patients
with repaired tetralogy of Fallot: A modeling study using patient-specific
CMR-based 2-layer anisotropic models of human right and left ventricles
Chun Yang, MS, Dalin Tang, PhD, FAHA, Tal Geva, MD, Rahul Rathod, MD,
Haruo Yamauchi, MD, PhD, Vasu Gooty, MD, Alexander Tang, Glenn Gaudette, PhD,
Kristen L. Billiar, PhD, Mehmet H. Kural, MS, and Pedro J. del Nido, MD, Worcester and Boston,
Mass; and Beijing, ChinaThe CMR-based RV/LV/patch/band model introduced in our report provides a proof of concept for
using elastic bands to improve RV cardiac function. Band insertion, combined with myocardium
regeneration and RV remodeling surgical procedures, has the potential to improve ventricular
function in patients with repaired TOF and other congenital heart diseases.
)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 145, Number 1 31AStefano Schena, MD, PhD, and Alexander S. Krupnick, MD, St. Louis, MoD
USurgical Techniques 295 A simplified technique for pulmonary artery aneurysm repair in a lung
transplant recipient with right ventricular outflow tract obstructionEGiorgio Zanotti, MD, Matthew G. Hartwig, MD, and R. Duane Davis, MD, Durham, NC297 Endoscopic tunneling of HeartMate II left ventricular assist device drivelineTSA. Dave Nagpal, MD, Brianne K. Larsen, PA, Nicholas G. Smedira, MD, and
Edward G. Soltesz, MD, Cleveland, OhioG299 Left-sided robotic thoracic duct clipping for chylothorax
Rafael P. Squitieri, MD, and Albert C. DiMeo, MD, Bridgeport, Conn300 Recurrent catamenial hemopneumothorax treated by coverage with
polyglycolic acid sheetsDCMamoru Takahashi, MD, Tadashi Matsukura, MD, PhD, Takashi Hirai, MD, PhD, and
Nobuya Mino, MD, PhD, Fukui and Shizuoka, Japan ABrief Research Reports 303 Aortic root numeric model: Correlation between intraoperative effective
height and diastolic coaptation
Gil Marom, MSc, Rami Haj-Ali, PhD, Moshe Rosenfeld, DSc, Hans Joachim Sch€afers, MD, and
Ehud Raanani, MD, Tel Aviv and Tel Hashomer, Israel; and Homburg, GermanyD305 Current results of open total arch replacement versus hybrid thoracic
endovascular aortic repair for aortic arch aneurysm: A meta-analysis of
comparative studiesCHUmberto Benedetto, MD, PhD, Giovanni Melina, MD, PhD, Emiliano Angeloni, MD,
Massimiliano Codispoti, MD, FRCS, and Riccardo Sinatra, MD, Rome, Italy, and Cambridge, UKTOnline Only:Case Reports
e1 False traumatic aneurysm of the aortic arch. Retrograde cerebral perfusion
obliged. A case report.XMichel F. Mitsomoy, MD, Reddy Atipo-Galloye, MD, Borgatia D. Atta, MD, and
Rochd Sayah, PhD, Rabat, Moroccoe3 Perigraft seroma mimicking cardiac tamponade after implantation of Berlin
Heart EXCOR device in an infantM
Fabrizio Gandolfo, MD, Gianluca Brancaccio, MD, PhD, Aurelio Secinaro, MD, and
Antonio Amodeo, MD, Rome, Italy Pe5 Management of secondary aortoesophageal fistula without graft extraction
Kazuya Kobayashi, MD, Toshihiro Ohata, MD, PhD, Hideki Ueda, MD, PhD, and
Toshiaki Shichinohe, MD, PhD, Sapporo, JapaneB
S7 Acute left ventricular failure after bilateral lung transplantation for idiopathic
pulmonary arterial hypertensionT/ETom Verbelen, MD, Sophie Van Cromphaut, MD, PhD, Filip Rega, MD, PhD, and
Bart Meyns, MD, PhD, Leuven, Belgium)
Table of Contents (continued)
ET/B
S
PM
CH
D
TX
CH
D
A
CD
G
TS
ED
ITO
RIA
L
TX
ED
U
G
TS
A
CD
CH
D
ET/B
S
PMe32A The Journal of Thoracic an9 Esophageal complications of catheter ablation for atrial fibrillation: A case
report(continued on page 34A
d Cardiovascular Surgery c January 2013Eitan Podgaetz, MD, MPH, and Claude Deschamps, MD, Boston, Mass, and Rochester,
Minne14 Aortic root thrombosis after transhiatal esophagectomy: A case report
Tomasz A. Timek, MD, Craig T. Alguire, MD, Kevin G. Wolschleger, MD, and
Mathew H. Chung, MD, Grand Rapids, Miche16 Subcostal to rib-cross incision for HeartMate II explantation: A case report
Takashi Nishimura, MD, Takeyoshi Ota, MD, PhD, Hiroo Takayama, MD, PhD, and
Yoshifumi Naka, MD, PhD, New York, NYLetters to the Editor 307 Screening with low-dose computed tomography: Response to The American
Association of Thoracic Surgery guidelines
Robert P. Young, BMedSc, MBChB, DPhil, FRACP, FRCP, and Raewyn J. Hopkins, BN, MPH,
Auckland, New Zealand308 Reply to the Editor
Michael T. Jaklitsch, MD, and Francine L. Jacobson, MD, MPH, Boston, Mass308 Correction of faulty assumptions in cost-effectiveness analysis
Matthew Reynolds, MD, MSc, Ann Thompson, BSN, MBA, and Francis Duhay, MD, MBA, Boston,
Mass, and Irvine, Calif309 Does albumin interfere with coagulation-related outcomes when comparing
colloids in cardiac surgery?
Ahmet Baris Durukan, MD, Murat Tavlasoglu, MD, and Hasan Alper Gurbuz, MD, Ankara, Turkey310 Reply to the Editor
Roberta J. Navickis, PhD, Gary R. Haynes, MD, PhD, and Mahlon M. Wilkes, PhD, Grass Valley,
Calif, and St Louis, Mo311 Aortic arch interruption without ductus arteriosus and no ventricular septal
defect
Carolina Putotto, MD, Marta Unolt, MD, and Dario Marino, MD, Rome, Italy311 Recognition and management of heparin-induced thrombocytopenia in
patients after cardiac surgery
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